Hepatitis C (HCV) is a major cause of liver disease, in which a third of individuals with
chronic HCV infections may develop liver cirrhosis. In a chronic HCV infection, host immune …

Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune
response, but they also have a distinct role in chronic infection. Here, we review the role of …

Background. Human immunodeficiency virus (HIV) may influence the outcome and natural
history of hepatitis C virus (HCV) infection through an impact on acute HCV-specific T cell …

Hepatitis C virus (HCV) is a worldwide health problem. No vaccine is available against this
pathogen and therapeutic treatments currently in use are of limited efficacy. In the present …

Human CMV establishes lifelong persistence after primary infection. Chronic CMV infection
is associated with intermittent viral reactivation inducing high frequencies of CD4+ T …

Hepatitis C virus (HCV) infection is a major cause of liver damage, with virus-induced end-
stage disease such as liver cirrhosis and hepatocellular carcinoma resulting in a high rate of …

Hepatitis C virus (HCV) establishes persistent infection in most infected patients, and
eventually causes chronic hepatitis, cirrhosis, and hepatocellular carcinoma in some …

The endocannabinoid (EC) system is implicated in many chronic liver diseases, including
hepatitis C viral (HCV) infection. Cannabis consumption is associated with fibrosis …

Background Hepatitis C virus (HCV) infection is a major cause of morbidity in HIV infected
individuals. Coinfection with HIV is associated with diminished HCV-specific immune …

Background The effect that high-dose interferon (IFN)–α induction therapy for hepatitis C
virus (HCV) infection has on cellular immune responses is currently unknown Methods Thirty …